Stellaris is passionately committed to pioneering an emerging and promising therapeutic approach with the potential to effectively reverse established fibrosis across various tissues and diseases. Stellaris has its roots in the globally recognized academic environments of UCLouvain and KU Leuven.
Company Details
- Founded
- 2023
- Address
- Rue Clément Ader 10, Charleroi,walloon Region 6041,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Stellaristherapeutics.com
- Keywords
- Railroad Therapeutics.
- HQ
- Charleroi, Walloon Region
Stellaris Therapeutics Questions
Stellaris Therapeutics's website is http://Stellaristherapeutics.com
Stellaris Therapeutics's LinkedIn profile is https://be.linkedin.com/company/stellaris-therapeutics
Stellaris Therapeutics's industry is
Biotechnology Research
Stellaris Therapeutics's top competitors are
Conveyxo,
Immunxperts, A Q² Solutions Company,
Brussels South Charleroi Biopark,
Mestastop® Solutions,
Immunofusion,
Railroad Therapeutics,
Hemastatx,
Endo Tools Therapeutics,
Cap4hr,
Iteos Therapeutics.
Stellaris Therapeutics's categories are Biotechnology Research
Stellaris Therapeutics's founding year is 2023
